C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients

Transplantation Proceedings

Volumn 36, Issue 9, 2004, Pages 2656-2658

  Ferraresso, M ^a,d   Citterio, F ^b   Ghio, L ^c   Romagnoli, J ^b   Edefonti, A ^b   Berardinelli, L ^a   Castagneto, M ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c PARKINSON INSTITUTE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CYCLOSPORINE; DRUG MONITORING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 11144258747     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.09.075     Document Type: Article

References (12)

1. G. Levy, E. Thervet, J. Lake Consensus on Neoral C(2): Expert Review in Transplantation (CONCERT) Group. Patient management by Neoral C(2) monitoring: an international consensus statement Transplantation 73 2002 12
2. K. Mahalati, P. Belitsky, I. Sketris Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation Transplantation 68 1999 55
3. G. Levy, P. Burra, A. Cavallari Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2) Transplantation 73 2002 953
4. M. Cantarovich, E. Elstein, B. de Varennes Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients Transplantation 68 1999 1839
5. P.F. Halloran, L.M. Helms, L. Kung The temporal profile of calcineurin inhibition by cyclosporine in vivo Transplantation 68 1999 1356
6. M. Ferraresso, L. Ghio, S.: Cyclosporine monitoring in stable, long-term, pediatric kidney transplant recipients: the value of C.2 determination Tirelli Transplant Proc 36 2004 685
7. R. Trompeter, M. Fitzpatrick, C. Hutchinson Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (Neoral) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption Pediatr Transplant 7 2003 282
8. B.D. Kahan, W.G. Kramer, C.A. Wideman Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine Transplant Proc 18 1986 115
9. R. Neiberger, R. Weiss, M. Gomez Elimination kinetics of cyclosporine following oral administration to children with renal transplants Transplant Proc 19 1987 1525
10. K. Hoppu, O. Koskimies, C. Holmberg Pharmacokinetically determined cyclosporine dosage in young children Pediatr Nephrol 5 1991 1
11. E. Cole, N. Maham, C. Cardella Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients Transplantation 75 2003 2086
12. K. Midtvedt, P. Fauchald, S. Bergan C2 monitoring in maintenance renal transplant recipients: is it worthwhile? Transplantation 76 2003 1236